Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00025389
Status:
COMPLETED
Last Update Posted:
2013-02-11
First Post:
2001-10-11
Brief Title:
Bevacizumab Paclitaxel and Carboplatin Before Surgery in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Cell Lung Cancer
Sponsor:
University of Chicago
Organization:
University of Chicago
Organization Data
Organization:
University of Chicago
Class:
OTHER
Study ID:
12653A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Chicago
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |